Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EEZK | ISIN: CA09237D1078 | Ticker-Symbol: QD6
Stuttgart
02.05.24
11:54 Uhr
0,013 Euro
+0,001
+8,70 %
1-Jahres-Chart
BLACKHAWK GROWTH CORP Chart 1 Jahr
5-Tage-Chart
BLACKHAWK GROWTH CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0110,02621:22
ACCESSWIRE
575 Leser
Artikel bewerten:
(2)

Blackhawk Growth Corp.: Blackhawk Showcases Life AI Corp Ahead of Closing of Hardenbrook Group Acquisition

VANCOUVER, BC / ACCESSWIRE / September 14, 2023 / Blackhawk Growth Corp. (CSE:BLR)(Frankfurt:0JJ) (the "Corporation" or "Blackhawk"), is pleased to showcase its upcoming health tech focused AI companies that will be acquired in the acquisition of Hardenbrook Group.

Whilst we progress with the pre-transaction requirements to complete the Hardenbrook Group acquisition, Hardenbrook's portfolio companies continue to progress their important scientific work in health technology and AI under the umbrella of Life AI Corp.

Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI. Life AI Corp will be the holding company for all health tech AI companies and will progress towards a public listing. https://www.lifeaicorp.com

Life AI Corp is working on a number of new globally scalable health tech focused AI companies that are conducting research, collecting data and creating machine learning models for new product development in a variety of health domains.

Life AI Corp is conducting leading research in asthma attack prediction and prevention, early detection of autism and prediction of negative mood states such as depression and anxiety for early prevention and intervention. It is also developing a learning model for human performance optimization and longevity. With enough clinical data, Health AI models can be productized and integrated to digital devices such as smart watches and mobile devices to accurately support health monitoring, deliver health interventions and promote health optimization and longer living.

The acquisition of Hardenbrook Group is subject to closing conditions including shareholder approval and we will provide updates on progress.

Blackhawk CEO Justin Hanka (left) and Chairman Anoosh Manzoori (right). Board to focus on scalable technology opportunities particularly in AI.

Hardenbrook Group, is an investment company that leverages a merchant banking model and works with world class research-intensive organizations including large tier 1 universities to identify valuable intellectual property to invest, commercialize and take public on stock exchanges in North America. Its portfolio company Life AI Corp is conducting clinical health research and product development across a number of domains and is working toward a spin out and public listing in 2024.

About Blackhawk Growth

Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high growth companies

To receive our latest updates, please register here:

For more information on Hardenbrook: https://www.hardenbrook.group.

For more information on Life AI Corp: https://www.lifeaicorp.com

Contact:

Justin Hanka
Chief Executive Officer
61433140886

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Blackhawk Growth Corp.

View source version on accesswire.com:
https://www.accesswire.com/784047/blackhawk-showcases-life-ai-corp-ahead-of-closing-of-hardenbrook-group-acquisition

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2023 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.